Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 156

1.

CSCI and the future of clinical health science research in Canada.

MacLeod SM.

Clin Invest Med. 2018 Nov 3;41:38-40. doi: 10.25011/cim.v41i2.31443.

PMID:
30394281
2.

Diversified Pediatric Pharmacoepidemiology: An International Priority.

MacLeod SM.

Paediatr Drugs. 2018 Oct;20(5):383-384. doi: 10.1007/s40272-018-0308-y. No abstract available.

PMID:
30141136
3.

Improving Medicine Use for Children: A Global Imperative.

MacLeod SM.

Clin Pharmacol Ther. 2017 Jun;101(6):715-717. doi: 10.1002/cpt.635. Epub 2017 Mar 20.

PMID:
28127760
4.

An International Asset Map of Clinicians, Educators, and Researchers Pursuing Better Medicine Use in Children: Initial Findings.

MacLeod SM, Greff M, Knoppert DC, Ito S, Rieder MJ.

Clin Pharmacol Ther. 2017 Feb;101(2):274-280. doi: 10.1002/cpt.460. Epub 2016 Sep 28.

PMID:
27556253
5.

Anthropometric measures are simple and accurate paediatric weight-prediction proxies in resource-poor settings with a high HIV prevalence.

Whitfield KC, Wozniak R, Pradinuk M, Karakochuk CD, Anabwani G, Daly Z, MacLeod SM, Larson CP, Green TJ.

Arch Dis Child. 2017 Jan;102(1):10-16. doi: 10.1136/archdischild-2015-309645. Epub 2016 Apr 12.

PMID:
27073160
6.

A quarter century of progress in paediatric clinical pharmacology: A personal view.

MacLeod SM.

Br J Clin Pharmacol. 2016 Feb;81(2):228-34. doi: 10.1111/bcp.12776. Epub 2015 Nov 10. No abstract available.

7.

Better therapies for children: a worldwide search for needed human resources.

MacLeod SM.

Paediatr Drugs. 2015 Jun;17(3):175-7. doi: 10.1007/s40272-015-0132-6.

PMID:
25956169
8.

A cohort study of morbidity, mortality and health seeking behavior following rural health center visits by children under 12 in southwestern Uganda.

Wiens MO, Gan H, Barigye C, Zhou G, Kumbakumba E, Kabakyenga J, Kissoon N, Ansermino JM, Karlen W, Larson CP, MacLeod SM.

PLoS One. 2015 Jan 30;10(1):e0118055. doi: 10.1371/journal.pone.0118055. eCollection 2015.

9.

A landmark report on improving medicines for children.

't Jong GW, Klassen TP, MacLeod SM.

JAMA Pediatr. 2015 Mar;169(3):204-5. doi: 10.1001/jamapediatrics.2014.3057. No abstract available.

PMID:
25561323
10.

Pediatric clinical drug trials in low-income countries: key ethical issues.

MacLeod SM, Knoppert DC, Stanton-Jean M, Avard D.

Paediatr Drugs. 2015 Feb;17(1):83-90. doi: 10.1007/s40272-014-0103-3. Review.

PMID:
25404352
11.

Controversial sodium guidelines: scientific solution or perpetual debate?

MacLeod SM, Cairns JA.

CMAJ. 2015 Feb 3;187(2):95-96. doi: 10.1503/cmaj.141011. Epub 2014 Nov 10. No abstract available.

12.

Canadian demand for highly qualified personnel for therapeutic evaluation: an opportunity for academic institutions.

MacLeod SM, Soon JA, Sharma S, Wiens MO.

J Popul Ther Clin Pharmacol. 2014;21(3):e379-86. Epub 2014 Oct 19.

PMID:
25347149
13.

Post-market drug evaluation research training capacity in Canada: an environmental scan of Canadian educational institutions.

Wiens MO, Soon JA, MacLeod SM, Sharma S, Patel A.

J Popul Ther Clin Pharmacol. 2014;21(3):e370-8. Epub 2014 Oct 19.

PMID:
25347114
14.

Screening and referral to identify children at risk for FASD: Search for new methods 2006-2013.

Koren G, Chudley A, Loock C, MacLeod SM, Orrbine E, Rosales T, Rosenbaum C, Sarkar M.

J Popul Ther Clin Pharmacol. 2014;21(2):e260-5. Epub 2014 Jul 9. Review.

PMID:
25019303
15.

A new toolkit for conducting clinical trials in rare disorders: will this dog hunt?

Peterson RG, Macleod SM, Klein AV.

J Popul Ther Clin Pharmacol. 2014;21(1):e79-80. Epub 2014 Feb 23. No abstract available.

PMID:
24671905
16.

Better drug therapy for the children of Africa: current impediments to success and potential strategies for improvement.

Macleod SM, Finch JK, Macharia WM, Anabwani GM.

Paediatr Drugs. 2013 Aug;15(4):259-69. doi: 10.1007/s40272-013-0015-7.

PMID:
23580345
17.

Patterns of paediatric analgesic use in Africa: a systematic review.

Madadi P, Enato EF, Fulga S, Umeoduagu CC, MacLeod SM, Koren G, Einarson TR.

Arch Dis Child. 2012 Dec;97(12):1086-91. doi: 10.1136/archdischild-2012-302386. Epub 2012 Sep 13. Review.

PMID:
22975843
18.

Prescription drug dispensing profiles for one million children: a population-based analysis.

Zhang T, Smith MA, Camp PG, Shajari S, MacLeod SM, Carleton BC.

Eur J Clin Pharmacol. 2013 Mar;69(3):581-8. doi: 10.1007/s00228-012-1343-1. Epub 2012 Jul 12.

PMID:
22791273
19.

Twisting the lion's tail: Collaborative health policy making in British Columbia.

Lindstrom RR, MacLeod SM, Levy A.

Healthc Pap. 2011;11(2):10-24.

PMID:
21677513
20.

Has the time come to phase out codeine?

MacDonald N, MacLeod SM.

CMAJ. 2010 Nov 23;182(17):1825. doi: 10.1503/cmaj.101411. Epub 2010 Oct 4. No abstract available.

21.

Self-reported use of natural health products: a cross-sectional telephone survey in older Ontarians.

Levine MA, Xu S, Gaebel K, Brazier N, B├ędard M, Brazil K, Lohfeld L, MacLeod SM.

Am J Geriatr Pharmacother. 2009 Dec;7(6):383-92. doi: 10.1016/j.amjopharm.2009.12.003.

PMID:
20129259
22.

Pediatric Drug Development: Concepts and Applications.

MacLeod SM.

Clin Pharmacol Ther. 2009 Dec;86(6):583-584. doi: 10.1038/clpt.2009.192. No abstract available.

PMID:
28547833
23.

The global alliance for pediatric pharmacology: the future is here and now.

Koren G, Rieder M, MacLeod SM.

Paediatr Drugs. 2009;11(1):4-5.

PMID:
19127940
24.

Improving drug treatment for children: are we making an impact?

MacLeod SM.

Paediatr Drugs. 2009;11(1):1-3.

PMID:
19127939
25.

Species interactions in mixed-community crystalline biofilms on urinary catheters.

Macleod SM, Stickler DJ.

J Med Microbiol. 2007 Nov;56(Pt 11):1549-57.

PMID:
17965358
26.
27.

A review of glaucoma treatment in Scotland 1994-2004.

Macleod SM, Clark R, Forrest J, Bain M, Bateman N, Azuara-Blanco A.

Eye (Lond). 2008 Feb;22(2):251-5. Epub 2006 Sep 22.

PMID:
17001326
28.

Observations on the adherence of Proteus mirabilis onto polymer surfaces.

Stickler DJ, Lear JC, Morris NS, Macleod SM, Downer A, Cadd DH, Feast WJ.

J Appl Microbiol. 2006 May;100(5):1028-33.

29.

Impact of antibiotic administrative restrictions on trends in antibiotic resistance.

Marshall DA, McGeer A, Gough J, Grootendorst P, Buitendyk M, Simonyi S, Green K, Jaszewski B, MacLeod SM, Low DE.

Can J Public Health. 2006 Mar-Apr;97(2):126-31.

PMID:
16620000
30.

Pharmacological treatment of ankylosing spondylitis: a systematic review.

Boulos P, Dougados M, Macleod SM, Hunsche E.

Drugs. 2005;65(15):2111-27. Review.

PMID:
16225367
31.

Resistance to antibiotics: administrative response to the challenge.

Marshall DA, McGeer AJ, Jaszewski BA, Grootendorst PV, Green KA, Laframboise MF, Lam LA, Low DE, MacLeod SM.

Manag Care Interface. 2004 Dec;17(12):20-9.

PMID:
15656376
32.

Hospitals and academic health sciences centres: leaders or followers in health globalization?

MacLeod SM.

Healthc Pap. 2003;4(2):64-8; discussion 76-81.

PMID:
14660887
33.

Patenting of genetic material: are the benefits to society being realized?

Willison DJ, MacLeod SM.

CMAJ. 2002 Aug 6;167(3):259-62. No abstract available.

34.

Experimental keloid scar models: a review of methodological issues.

Hillmer MP, MacLeod SM.

J Cutan Med Surg. 2002 Jul-Aug;6(4):354-9. Epub 2002 Jul 16. Review.

PMID:
12118348
35.

Prescription data.

MacLeod SM.

CMAJ. 2001 May 15;164(10):1409; author reply 1409-10. No abstract available.

36.

Surviving the tsunami of drug therapy expenditures.

MacLeod SM.

Can J Clin Pharmacol. 2000 Summer;7(2):83-4. No abstract available.

PMID:
10958701
37.

Dry powder versus intravenous and nebulized gentamicin in cystic fibrosis and bronchiectasis. A pilot study.

Crowther Labiris NR, Holbrook AM, Chrystyn H, Macleod SM, Newhouse MT.

Am J Respir Crit Care Med. 1999 Nov;160(5 Pt 1):1711-6.

PMID:
10556145
38.
39.

Basic science in medical education.

MacLeod SM.

Clin Invest Med. 1999 Feb;22(1):23-4. No abstract available.

PMID:
10079992
40.

Paediatric pharmacology and toxicology: Drug therapy research for children rather than on children.

Macleod SM.

Paediatr Child Health. 1998 Nov;3(6):393-4. No abstract available.

41.

Evidence-based rationing: Dutch pragmatism or government insensitivity?

MacLeod SM, Bienenstock J.

CMAJ. 1998 Jan 27;158(2):213-4. No abstract available.

42.

Report of ACMC annual meeting. Summary of proceedings: the second set report to plenary session, May 6, 1997.

MacLeod SM.

Clin Invest Med. 1997 Dec;20(6):428-32. No abstract available.

PMID:
9453883
43.

Report on ACMC annual meeting. Summary of proceedings: the first set report to plenary session, May 5, 1997.

MacLeod SM.

Clin Invest Med. 1997 Dec;20(6):422-7. No abstract available.

PMID:
9453882
44.

Change and the academic health science centre: a 1997 perspective.

MacLeod SM.

Clin Invest Med. 1997 Dec;20(6):399-404. No abstract available.

PMID:
9413637
45.

Research in medical schools: rationale, priorities, roles and balance.

MacLeod SM.

Clin Invest Med. 1996 Jun;19(3):204-13.

PMID:
8724825
46.
47.
48.

The WHO. The tropical disease research programme has a coherent plan.

MacLeod SM.

BMJ. 1995 Mar 4;310(6979):596. No abstract available.

49.

Social science education as a component of medical training.

MacLeod SM, McCullough HN.

Soc Sci Med. 1994 Nov;39(9):1367-73. Review.

PMID:
7801172
50.

Undergraduate medical education. Too many facts not enough innovation.

MacLeod SM.

BMJ. 1993 Dec 11;307(6918):1565-6. No abstract available.

Supplemental Content

Loading ...
Support Center